Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Jan
29
2024
Discussion in Mexico About the Deadline to File Non-Use Cancellation Actions Against Anticipations Cited in the Trademark Registration Process OLIVARES
Jan
29
2024
When Will the LLM Patent Wave Hit? Foley & Lardner LLP
Jan
28
2024
China’s Supreme People’s Court Upholds 201.54 Million RMB Trade Secret Verdict Schwegman, Lundberg & Woessner, P.A.
Jan
27
2024
China’s Supreme People’s Court Clarifies Conditions Needed to Prove Patent Infringement Lawsuit Filed in Bad Faith Schwegman, Lundberg & Woessner, P.A.
Jan
25
2024
First Amendment Bowled Over by Lanham Act – Again McDermott Will & Emery
Jan
25
2024
Keep Calm and Party On: New Issue Prohibition Doesn’t Apply to Motions to Amend McDermott Will & Emery
Jan
25
2024
Don’t Cut, Paste, Copyright: Bonding over Borrowed Words McDermott Will & Emery
Jan
24
2024
How Compulsory Licenses Can Affect Domestic and Foreign Prosecution Mintz
Jan
24
2024
Startup Advisors: What is Vesting and Why is it Important? [Video] Foley & Lardner LLP
Jan
24
2024
The #AD Vantage Point: Navigating the FTC Endorsement Guides, Part III Ward and Smith, P.A.
Jan
24
2024
Spilling Secrets Podcast: Invention Ownership - Why the Tense Matters in Employee IP Provisions [Podcast] Epstein Becker & Green, P.C.
Jan
23
2024
5 Trends to Watch: 2024 Trademark and Brand Management Greenberg Traurig, LLP
Jan
23
2024
China Trademark Registrations Down 29% in 2023 Schwegman, Lundberg & Woessner, P.A.
Jan
23
2024
Name, Image & Likeness: New Class Action Could Determine Whether NIL Activities Are Subject To US Federal Law Prohibiting Sex Discrimination In Education Squire Patton Boggs (US) LLP
Jan
22
2024
Beijing Internet Court Releases Translation of Li vs. Liu Recognizing Copyright in Generative AI Schwegman, Lundberg & Woessner, P.A.
Jan
22
2024
Navigating the Evolving NIL Landscape: NCAA Proposals, Federal Contradictions, and Ongoing Challenges in 2024 Bradley Arant Boult Cummings LLP
Jan
22
2024
Federal Judge Rejects Pharma Manufacturers’ Challenge to Negative OIG Advisory Opinion Mintz
Jan
22
2024
Identifying Protocols by Name May Disclose Sufficient Structure for Computer-Implemented Means-Plus-Function Limitations Sheppard, Mullin, Richter & Hampton LLP
Jan
22
2024
The Importance of Reasonable Particularity in a Doctrine of Equivalents Argument Sheppard, Mullin, Richter & Hampton LLP
Jan
22
2024
Court Rules that Patient List and Related Medical Practice Information Qualify as Trade Secrets Proskauer Rose LLP
Jan
22
2024
AI Art Registration Denied – The Copyright Review Board Tells Applicant To Gogh Home Squire Patton Boggs (US) LLP
Jan
22
2024
Enablement Post-Amgen and New USPTO Guidelines Womble Bond Dickinson (US) LLP
Jan
21
2024
CNIPA Posts “Development Report on Building a Powerful Country on Intellectual Property Rights (2023)” Schwegman, Lundberg & Woessner, P.A.
Jan
19
2024
Huawei U.S. Patent Grants Drop 24% in 2023; BOE Drops Out of the Top 10 Schwegman, Lundberg & Woessner, P.A.
Jan
19
2024
Watch Post-Amgen Enablement Case Law as the United States Patent and Trademark Office Continues to Use Wands Analysis in View of Amgen v. Sanofi Womble Bond Dickinson (US) LLP
Jan
19
2024
What the U.S. and EU are Doing to Mitigate the Legal Risks to the Rights of Privacy and Publicity, and Intellectual Property Posed by AI Norris McLaughlin P.A.
Jan
18
2024
Federal Circuit Affirms Skinny Label Carve Outs Sheppard, Mullin, Richter & Hampton LLP
Jan
18
2024
Shazam! Captain Cannabis Registration Defeated by Prior Analogous Trademark Use McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins